Dermapharm Holding SE (LON:0A5J)

Market Cap	1.59B +1.9%
Revenue (ttm)	1.02B +0.4%
Net Income	126.18M +36.7%
EPS	2.32 +39.0%
Shares Out	n/a
PE Ratio	13.82
Forward PE	13.00
Dividend	0.77 (2.40%)
Ex-Dividend Date	Jun 29, 2026

Volume	382
Open	38.60
Previous Close	38.20
Day's Range	38.30 - 38.60
52-Week Range	33.00 - 51.70
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 3,619
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A5J

Financial Performance

In 2025, Dermapharm Holding SE's revenue was 1.17 billion, a decrease of -1.32% compared to the previous year's 1.18 billion. Earnings were 132.41 million, an increase of 16.37%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 10, 2026

Data Sources Report a data error